Karyopharm Therapeutics Inc.

0.95 USD
-0.01 (-1.39%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Karyopharm Therapeutics Inc. stock is down -7.86% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 10 July’s closed higher than June. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
25 Jun 17:57 15 Nov, 2024 1.00 CALL 1000 1386

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company has license agreement with Menarini Group to develop and commercialize NEXPOVIO for human oncology indications in Europe, including the United Kingdom; Latin America; and other countries.